Cargando…
Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests
Expanding hepatitis C virus (HCV) treatment coverage is challenged by limited testing and diagnosis. This study assessed the risk of exposure, for the Middle East and North Africa, by population, yields of testing, and program efficiency of testing strategies. A standardized and systematically assem...
Autores principales: | Chemaitelly, Hiam, Mahmud, Sarwat, Kouyoumjian, Silva P., Al‐Kanaani, Zaina, Hermez, Joumana G., Abu‐Raddad, Laith J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396361/ https://www.ncbi.nlm.nih.gov/pubmed/30859146 http://dx.doi.org/10.1002/hep4.1310 |
Ejemplares similares
-
The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2020) -
Key associations for hepatitis C virus genotypes in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2019) -
Hepatitis C Virus Infection in Populations With Liver‐Related Diseases in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2020) -
Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns
por: Mahmud, Sarwat, et al.
Publicado: (2017) -
Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses
por: Mahmud, Sarwat, et al.
Publicado: (2022)